 | Up a level |
Patsenker, Eleanora; Sachse, Philip; Chicca, Andrea; Gachet Otanez, Maria Salomé; Schneider, Vreni; Mattsson, Johan; Lanz, Christian; Worni, Mathias; De Gottardi, Andrea; Semmo, Mariam; Hampe, Jochen; Schafmayer, Clemens; Brenneisen, Rudolf Max; Gertsch, Jürg; Stickel, Felix; Semmo, Nasser (2015). Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation. International journal of molecular sciences, 16(4), pp. 7057-7076. Molecular Diversity Preservation International MDPI 10.3390/ijms16047057
Patsenker, Eleanora; Sachse, Philip; Mattsson, Johan; Lanz, Christian; Schneider, Vreni; Brenneisen, Rudolf Max; De Gottardi, Andrea; Dufour, Jean-François; Stickel, Felix; Semmo, Nasser (April 2014). Endocannabinoids Suppress Cytokine Secretion in HCV Infection (Unpublished). In: EASL International Liver Congress 2014. London, UK. 09.-13.04.2014.
Patsenker, Eleonora; Stoll, Matthias; Millonig, Gunda; Agaimy, Abbas; Wissniowski, Till; Schneider, Vreni; Mueller, Sebastian; Brenneisen, Rudolf; Seitz, Helmut K; Ocker, Matthias; Stickel, Felix (2011). Cannabinoid receptor type I modulates alcohol-induced liver fibrosis. Molecular medicine, 17(11-12), pp. 1285-94. Manhasset, NY: Feinstein Institute for Medical Research 10.2119/molmed.2011.00149
Patsenker, Eleonora; Schneider, Vreni; Ledermann, Monika; Saegesser, Hans; Dorn, Christoph; Hellerbrand, Claus; Stickel, Felix (2011). Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis. Journal of hepatology, 55(2), pp. 388-98. Amsterdam: Elsevier 10.1016/j.jhep.2010.10.044
Patsenker, Eleonora; Popov, Yury; Stickel, Felix; Schneider, Vreni; Ledermann, Monika; Sägesser, Hans; Niedobitek, Gerald; Goodman, Simon L; Schuppan, Detlef (2009). Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis. Hepatology, 50(5), pp. 1501-11. Hoboken, N.J.: Wiley Interscience 10.1002/hep.23144
Stickel, Felix; Osterreicher, Christoph H; Halangk, Juliane; Berg, Thomas; Homann, Nils; Hellerbrand, Claus; Patsenker, Eleonora; Schneider, Vreni; Kolb, Armin; Friess, Helmut; Schuppan, Detlef; Puhl, Gero; Seitz, Helmut K; Leathart, Julian L B; Day, Christopher P (2008). No role of matrixmetalloproteinase-3 genetic promoter polymorphism 1171 as a risk factor for cirrhosis in alcoholic liver disease. Alcoholism: clinical and experimental research, 32(6), pp. 959-65. Oxford: Wiley-Blackwell 10.1111/j.1530-0277.2008.00654.x
Neef, Markus; Ledermann, Monika; Saegesser, Hans; Schneider, Vreni; Reichen, Juerg (2006). Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis. Journal of hepatology, 45(6), pp. 786-96. Amsterdam: Elsevier 10.1016/j.jhep.2006.07.030
Neef, Markus; Ledermann, Monika; Saegesser, Hans; Schneider, Vreni; Widmer, Nicolas; Decosterd, Laurent Arthur; Rochat, Bertrand; Reichen, Juerg (2006). Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term. Journal of hepatology, 44(1), pp. 167-75. Amsterdam: Elsevier 10.1016/j.jhep.2005.06.015
